U.S. Markets closed

IntelliPharmaCeutics International (IPCI) Soars: Stock Rises 9.1%

Zacks Equity Research

IntelliPharmaCeutics International Inc. (IPCI) was a big mover last session, as its shares rose over 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the healthcare company since Mar 13, as the stock is now up over 4%.

In the last 30-day frame, the company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting solid trade ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

IntelliPharmaCeutics currently carries a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Other well-performing stocks in the medical sector include WuXi PharmaTech (Cayman) Inc. (WX), BioLineRx, Ltd. (BLRX) and Cardiome Pharma Corp. .(CRME). All three carry the same Zacks Rank as IntelliPharmaCeutics.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


WUXI PHARMATECH CAYMAN INC (WX): Free Stock Analysis Report

BIOLINERX LTD ADS (BLRX): Free Stock Analysis Report

CARDIOME PHARMA CORP ORD (CRME): Free Stock Analysis Report

Zacks Investment Research